Anton Megens

1.3k total citations
31 papers, 1.1k citations indexed

About

Anton Megens is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Anton Megens has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 9 papers in Pharmacology. Recurrent topics in Anton Megens's work include Receptor Mechanisms and Signaling (11 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Neuroscience and Neuropharmacology Research (5 papers). Anton Megens is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Neuroscience and Neuropharmacology Research (5 papers). Anton Megens collaborates with scholars based in Belgium, United States and Netherlands. Anton Megens's co-authors include F. Awouters, C. J. E. Niemegeers, Paul A. J. Janssen, T. Meert, K H Schellekens, Josée E. Leysen, José Manuel Alonso Segura, José M. Cid, Laura Iturrino and José Ignacio Andrés and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Psychopharmacology.

In The Last Decade

Anton Megens

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anton Megens Belgium	17	373	355	285	217	183	31	1.1k
Zsolt Szombathelyi Hungary	15	338 0.9×	488 1.4×	362 1.3×	145 0.7×	133 0.7×	34	969
Elaine Ryan United States	12	274 0.7×	349 1.0×	429 1.5×	190 0.9×	133 0.7×	17	1.1k
Marie‐Bernadette Assié France	19	500 1.3×	765 2.2×	208 0.7×	139 0.6×	122 0.7×	25	1.1k
Károly Tihanyi Hungary	19	436 1.2×	409 1.2×	325 1.1×	87 0.4×	159 0.9×	51	1.4k
Penny G. Threlkeld United States	18	428 1.1×	752 2.1×	183 0.6×	102 0.5×	239 1.3×	23	1.2k
Yasufumi Uwahodo Japan	12	308 0.8×	309 0.9×	243 0.9×	124 0.6×	96 0.5×	18	794
Deborah K. Hyslop United States	12	324 0.9×	515 1.5×	122 0.4×	93 0.4×	142 0.8×	19	900
Aron D. Mosnaim United States	20	351 0.9×	378 1.1×	294 1.0×	101 0.5×	202 1.1×	85	1.3k
Giovanna Guiso Italy	21	384 1.0×	458 1.3×	439 1.5×	80 0.4×	229 1.3×	65	1.6k
Laurence R. Meyerson United States	23	650 1.7×	775 2.2×	158 0.6×	172 0.8×	212 1.2×	56	1.5k

Countries citing papers authored by Anton Megens

Since Specialization

Citations

This map shows the geographic impact of Anton Megens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Megens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Megens more than expected).

Fields of papers citing papers by Anton Megens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Megens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Megens. The network helps show where Anton Megens may publish in the future.

Co-authorship network of co-authors of Anton Megens

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Megens. A scholar is included among the top collaborators of Anton Megens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Megens. Anton Megens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bartolomé-Nebreda, José Manuel, Marta Artola, Francisca Delgado, et al.. (2014). Identification of a Novel Orally Bioavailable Phosphodiesterase 10A (PDE10A) Inhibitor with Efficacy in Animal Models of Schizophrenia.. Journal of Medicinal Chemistry. 58(2). 978–993. 15 indexed citations

Megens, Anton, Xavier Langlois, Ilse Lenaerts, et al.. (2014). Pharmacology of JNJ-42314415, a Centrally Active Phosphodiesterase 10A (PDE10A) Inhibitor: A Comparison of PDE10A Inhibitors with D2 Receptor Blockers as Potential Antipsychotic Drugs. Journal of Pharmacology and Experimental Therapeutics. 349(1). 138–154. 31 indexed citations

Megens, Anton, et al.. (2013). Differential Interaction of Neuroleptics with Apomorphine-Induced Behavior in Rats as a Function of Changing Levels of Dopamine Receptor Stimulation. Journal of Pharmacology and Experimental Therapeutics. 347(3). 681–696. 1 indexed citations

Eichenbaum, Gary, Alfred Tonelli, Lieve Lammens, et al.. (2010). Gavage-Related Reflux in Rats. Toxicologic Pathology. 39(2). 348–360. 73 indexed citations

Peremans, Kathelijne, Bart De Spiegeleer, Erik Buntinx, et al.. (2008). Evaluation of serotonin-2A receptor occupancy with 123I-5-I-R91150 and single-photon emission tomography before and after low-dose pipamperone administration in the canine brain. Nuclear Medicine Communications. 29(8). 724–729. 10 indexed citations

Eichenbaum, Gary, Joe Nguyen, Herman Borghys, et al.. (2006). Preclinical Assessment of the Feasibility of Applying Controlled Release Oral Drug Delivery to a Lead Series of Atypical Antipsychotics. Journal of Pharmaceutical Sciences. 95(4). 883–895. 3 indexed citations

Bruin, Natasja de, et al.. (2006). Performance of F2 B6x129 hybrid mice in the Morris water maze, latent inhibition and prepulse inhibition paradigms: Comparison with C57Bl/6J and 129sv inbred mice. Behavioural Brain Research. 172(1). 122–134. 15 indexed citations

Bruin, Natasja de, et al.. (2006). Attentional performance of (C57BL/6J×129Sv)F2 mice in the five-choice serial reaction time task. Physiology & Behavior. 89(5). 692–703. 33 indexed citations

Lavreysen, Hilde, Arjan Buist, Xavier Langlois, et al.. (2005). In vitro and in vivo activities of the mGlu1 receptor negative allosteric modulator JNJ16259685. Neuropharmacology. 49. 252–253. 3 indexed citations

10.

Alcudia, Ana, José Ignacio Andrés, José M. Cid, et al.. (2005). Novel 2-N,N-dimethylaminomethyl-2,3,3a,12b-tetrahydrodibenzo[b,f]furo[2,3-d]oxepin derivatives displaying combined norepinephrine reuptake inhibition and 5-HT2A/2C receptor antagonism. Bioorganic & Medicinal Chemistry Letters. 15(11). 2898–2901. 7 indexed citations

11.

Cid, José M., José Manuel Alonso Segura, José Ignacio Andrés, et al.. (2004). Synthesis and structure–activity relationship of 2-(aminoalkyl)-3,3a,8,12b-tetrahydro-2H-dibenzocyclohepta[1,2-b]furan derivatives: a novel series of 5-HT2A/2C receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(11). 2765–2771. 12 indexed citations

12.

Andrés, José Ignacio, Jesús Alcázar, José Manuel Alonso Segura, et al.. (2003). Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and α2-adrenoceptor antagonistic activities: a novel series of potential antidepressants. Bioorganic & Medicinal Chemistry Letters. 13(16). 2719–2725. 23 indexed citations

13.

Andrés, José Ignacio, José Manuel Alonso Segura, Javier Fernández, et al.. (2002). Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(4). 653–658. 21 indexed citations

14.

Andrés, José Ignacio, Jesús Alcázar, José Manuel Alonso Segura, et al.. (2002). Synthesis and structure–Activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT2A/2C receptor antagonists. Part 2. Bioorganic & Medicinal Chemistry Letters. 12(2). 249–253. 5 indexed citations

15.

Janssen, Paul A. J., Josée E. Leysen, Anton Megens, & F. Awouters. (1999). Does phenylethylamine act as an endogenous amphetamine in some patients?. The International Journal of Neuropsychopharmacology. 2(3). 229–240. 70 indexed citations

16.

Megens, Anton & Ludo Kennis. (1996). 5 Risperidone and related 5HT2/D2 antagonists: A new type of antipsychotic agent?. Progress in medicinal chemistry. 33. 185–232. 5 indexed citations

17.

Megens, Anton, et al.. (1989). Is in vivo dissociation between the antipropulsive and antidiarrheal properties of opioids in rats related to gut selectivity?. PubMed. 298. 220–9. 12 indexed citations

18.

Megens, Anton, F. Awouters, & C. J. E. Niemegeers. (1989). Interaction of haloperidol and risperidone (R 64 766) with amphetamine‐induced motility changes in rats. Drug Development Research. 17(1). 23–33. 16 indexed citations

19.

Megens, Anton, F. Awouters, & C. J. E. Niemegeers. (1988). Differential effects of the new antipsychotic risperidone on large and small motor movements in rats: a comparison with haloperidol. Psychopharmacology. 95(4). 493–6. 29 indexed citations

20.

Megens, Anton, et al.. (1987). Behavioural activity of rats measured by a new method based on the piezo-electric principle. Psychopharmacology. 93(3). 382–8. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact